Sunshine Guojian Pharmaceutical (Shanghai) Company Description

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

Its products include Enbrel, a recombinant human type II tumor necrosis factor receptor-antibody fusion protein for the treatment of autoimmune rheumatism and immunology; Jiannipa, a recombinant anti-CD25 humanized monoclonal antibody injection to prevent acute rejection caused by kidney transplantation; and Enbrel, an anti-IL-17A humanized monoclonal antibody ambroxol injection for the treatment of moderate to severe plaque psoriasis.

The company was founded in 2002 and is based in Shanghai, China.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Country	China
Founded	2002
Industry	Biotechnology
Sector	Healthcare
Employees	1,012
CEO	Yanli Liu

Contact Details

Address: No. 399, Libing Road Shanghai, 201203 China
Phone	86 21 8029 7676
Website	3s-guojian.com

Stock Details

Ticker Symbol	688336
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE1000062X2
SIC Code	2836

Key Executives

Name	Position
Yanli Liu	GM and Director
Hongmei Niu	Chief Financial Officer
Qi Zhang	Secretary of Board of Directors
Lirong Zheng	Accounting Supervisor